Hypoglycemia Prevention Starts in Primary Care: Evidence-Based Interventions for Mitigating Risk and Improving Patient Outcomes
October 23, 2020
October 23, 2021
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
Supported by an educational grant from Lilly.
- Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
- Nurses — maximum of 1.5 Contact Hours
All other health care professionals completing this course will be issued a statement of participation.
This educational program is directed toward primary care providers (physicians, nurse practitioners, and physician assistants) who treat patients with type 1 and type 2 diabetes.
In this online, on-demand virtual webcast, expert faculty review key resources, updated guidelines, and current standards of care for identifying and managing patients at risk for hypoglycemia. Faculty will discuss preventive strategies and describe newer options for treatment of severe hypoglycemic episodes. Patient case presentations and the recorded Q&A session will help to focus the discussions on clinical practice.
This educational activity is an archive of a webcast held September 22, 2020.
Upon completion of this activity, participants should be better able to:
- Recognize the risk and occurrence of hypoglycemia in the management of patients with diabetes
- Integrate new guideline recommendations in the prevention of hypoglycemic events into practice for patients with diabetes
- Describe how patients at risk for severe hypoglycemic episodes and their caregivers can be counseled on how to use new hypoglycemic rescue products
- Evaluate the efficacy and safety of newly approved and emerging therapeutic agents for severe hypoglycemic episodes to reduce fear and barriers associated with decisions to intensify dosing of antihyperglycemic therapies
Anne Peters, MD
Director, USC Clinical Diabetes Programs
Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, CA
Paul P. Doghramji, MD, FAAFP
Senior Family Physician
Collegeville Family Practice
Medical Director of Health Services
Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Disclosures of Conflicts of Interest
In accordance with ACCME guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Anne Peters, MD
- Grant/Research Support: Dexcom, vTvTherapeutics
- Consultant: Abbott Diabetes Care, Boehringer Ingelheim, Eli Lilly and Company, Livongo, MannKind, Merck, Novo Nordisk, Sanofi, Pendulum Therapeutics
- Speaker’s Bureau: Novo Nodisk
- Stock Options: Mellitus Health, Omada Health, Stability Health, Pendulum Therapeutics, Livongo
Paul P. Doghramji, MD, FAAFP
- No relevant financial relationships with commercial interests.
The staff of Physicians’ Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Complete the activity (including pre- and postactivity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.